What does GSK plc hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

GSK plc filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

CRISPR THERAPEUTICS AG

$153M3.2M25.6%

WAVE LIFE SCIENCES LTD

$132M18.2M22.1%

BIONTECH SE

$79M890K13.2%

VIR BIOTECHNOLOGY INC

$77M8.6M12.8%

IDEAYA BIOSCIENCES INC

$44M1.3M7.4%

LYELL IMMUNOPHARMA INC

$30M1.5M5.1%

CYTOKINETICS INC

$22M340K3.7%

SPERO THERAPEUTICS INC

$22M9.2M3.6%

FULCRUM THERAPEUTICS INC

$14M1.8M2.3%

CVRX INC

$10M1.0M1.6%

Filing history loading…